HUTCHMED (LON:HCM) Share Price Crosses Below Two Hundred Day Moving Average – Here’s Why

HUTCHMED (China) Limited (LON:HCM)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 289.99 ($3.65) and traded as low as GBX 261 ($3.29). HUTCHMED shares last traded at GBX 264 ($3.33), with a volume of 39,973 shares changing hands.

HUTCHMED Price Performance

The stock’s fifty day simple moving average is GBX 284.76 and its 200 day simple moving average is GBX 289.81. The company has a debt-to-equity ratio of 11.78, a current ratio of 2.81 and a quick ratio of 2.97. The firm has a market capitalization of £2.26 billion, a P/E ratio of -6,600.00 and a beta of 0.76.

About HUTCHMED

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.